When Marc Beer co-found Renovia in 2016, he was on the mission of developing digital therapeutic and diagnostic devices to treat pelvic floor disorders. Research sources reported a common disorder, known as urinary incontinence affects over 20 million women in the United States. Approximately 61 percent of those women under the age of 60 experience leakage which is treatable sometimes through exercising and strengthening the pelvic floor. Women’s Preventive Services Initiative (WPSI) and The American College of Obstetricians and Gynecologists (ACOG) released recommendations and opinions on the importance of urinary incontinence screening. Renovia is supporting the initiatives of the organizations to improve and maintain the health of women.
Renovia made the announcement in a press release on August 28th, 2018 of their support for urinary incontinence screening recommendations by ACOG and WPSI. As part of postpartum care for women, ACOG released its Committee Opinion-736 which recommends the screening for various pelvic floor disorders. ACOG leads national coalition, WPSI which released the first screening guidelines for detection and routine screening of all women including those in their adolescence. Women’s Preventive Services Initiative published the guidelines on August 14th to encourage early detection of urinary incontinence disorders and alternative treatments. Marc Beer and the Renovia team are dedicated to bringing awareness to millions of women and continuously supporting the initiatives of WPSI and The American College of Obstetricians and Gynecologists.
During the same year of supporting ACOG and WPSI, Marc Beer helped Renovia raise $42 million in Series B funds and venture debt. These funds are for developing and testing new products for therapeutic treatments and diagnostics. Marc and his partners received funding from healthcare investment firm, The Longwood Fund. Renovia is a med-tech company in Boston, Massachusetts and producer of FDA-approved device, Leva Pelvic Digital Health System. The device is for treating urinary incontinence and stress, and for strengthening the pelvic floor muscles through exercises.
Marc Beer serves as CEO and Chairman of Renovia for nearly three years with partners, Yolanda Lorie and Ramon Iglesias. He has 26 years of experience in the development and commercialization of biotechnology, diagnostics, pharmaceuticals, and a variety of devices. Before co-founding Renovia, Beer earned a bachelor’s degree from Miami University and joined Abbott Laboratories working in the sales and marketing. He left Abbot to serve as vice president of global marketing for Genzyme and later years later worked as CEO for Viacell. Learn more: https://www.crunchbase.com/person/marc-beer